Analyst Ratings for Celgene (celg)
celg Rating Summary
celg Price Target Summary
- Highest: $152.00 (Jefferies)
- Lowest: $47.00 (Citadel Securities)
- Average: $94.55
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$94.55 (-22.9%)
Avg. $ Target:
$94.55 (-22.9%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/5/2013 | Deutsche Bank | Upgrade | Buy (Hold) |
143.00 (105.00) |
115.95 | 122.58 | 5.72% | Details |
| 2/8/2013 | JMP Securities | New Coverage | Market Outperform (N/A) |
130.00 (N/A) |
97.84 | 122.58 | 25.29% | Details |
| 1/15/2013 | BofA/Merrill Lynch | Upgrade | Buy (Neutral) |
N/A (N/A) |
97.67 | 122.58 | 25.5% | Details |
| 1/8/2013 | RBC Capital | Upgrade | Outperform (Sector Perform) |
100.00 (90.00) |
85.73 | 122.58 | 42.98% | Details |
| 1/8/2013 | Piper Jaffray | Upgrade | Overweight (Neutral) |
111.00 (86.00) |
85.73 | 122.58 | 42.98% | Details |
| 12/13/2012 | Goldman Sachs | New Coverage | Neutral (N/A) |
77.00 (N/A) |
81.19 | 122.58 | 50.98% | Details |
| 11/21/2012 | Brean Capital | New Coverage | Buy (N/A) |
100.00 (N/A) |
77.12 | 122.58 | 58.95% | Details |
| 11/9/2012 | Guggenheim | New Coverage | Buy (N/A) |
96.00 (N/A) |
71.30 | 122.58 | 71.92% | Details |
| 10/15/2012 | Oppenheimer | Downgrade | Perform (Outperform) |
N/A (N/A) |
78.42 | 122.58 | 56.31% | Details |
| 9/10/2012 | UBS | Downgrade | Neutral (Buy) |
N/A (N/A) |
75.44 | 122.58 | 62.49% | Details |
| 9/5/2012 | WallachBeth Capital | New Coverage | Buy (N/A) |
82.00 (N/A) |
72.07 | 122.58 | 70.08% | Details |
| 6/29/2012 | Argus | Upgrade | Buy (Hold) |
N/A (N/A) |
62.05 | 122.58 | 97.55% | Details |
| 6/26/2012 | Cowen | Upgrade | Outperform (Neutral) |
N/A (N/A) |
61.23 | 122.58 | 100.2% | Details |
| 4/13/2012 | Auriga | Downgrade | Hold (N/A) |
82.00 (N/A) |
78.58 | 122.58 | 55.99% | Details |
| 4/4/2012 | Cantor Fitzgerald » Updated 11/12/2012 |
New Coverage | Buy (N/A) |
96.00 (82.00) |
80.29 | 122.58 | 52.67% | Details |
